Genetic testing for lung cancer risk: If physicians can do it, should they?

Journal of General Internal Medicine

Volumn 17, Issue 12, 2002, Pages 946-951

  Marcy, Theodore W ^a,b   Stefanek, Michael ^a   Thompson, Kimberly M ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Genetic counseling; Genetic screening; Lung neoplasms; Smoking

Indexed keywords

CYTOCHROME P450 2D6;

CANCER RISK; CAUSE OF DEATH; CLINICAL TRIAL; EARLY DIAGNOSIS; GENETIC RISK; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LUNG CARCINOMA; MOTIVATION; PHYSICIAN; PREVALENCE; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SMOKING CESSATION; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; GENETICS; GENETICS AND REPRODUCTION; HEALTH BEHAVIOR; LUNG TUMOR; MASS SCREENING; RISK FACTOR; SMOKING;

GENETICS AND REPRODUCTION;

HEALTH BEHAVIOR; HUMANS; LUNG NEOPLASMS; MASS SCREENING; RISK FACTORS; SMOKING;

EID: 0036460812     PISSN: 08848734     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1497.2002.20378.x     Document Type: Review

References (36)

1. Khoury M. From genes to public health: The applications of genetic technology in disease prevention. Am J Public Health. 1996;86:1717-22.
2. Hartmann L, Sellers T, Schald D, et al. Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst. 2001;93:1633-7.
3. Burke W, Daly M, Garber J, Botkin J, Kahn M, Lynch P. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. JAMA. 1997;277:997-1003.
4. Stefanek M, Hartmann L, Nelson W. Risk-reduction mastectomy: Clinical issues and research needs. J Natl Cancer Inst. 2001;93:1297-306.
5. Marteau T, Croyle R. Psychological responses to genetic testing. BMJ. 1998;316:693-6.
6. Wingo P, Ries L, Giovino G, et al. Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. J Natl Cancer Inst. 1999;91:675-90.
7. Samet J, Wiggins C, Humble C, Pathak D. Cigarette smoking and lung cancer in New Mexico. Am Rev Respir Dis. 1988;137:1110-3.
8. Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. The Health Benefits of Smoking Cessation. Washington, DC: U.S. Department of Health and Human Services; 1990. DHHS Publication No. (CDC) 90-8416.
9. Amos C, Caporaso N, Weston A. Host factors in lung cancer risk: A review of interdisciplinary studies. Cancer Epidemiol Biomarkers Prev. 1992;1:505-13.
10. Steiner E, Iselius L, Alvan G, Lidnsten J, Sjoqvist F. A family study of genetic and environmental factors determining polymorphic hydroxylation of debrisoquin. Clin Pharmacol Ther. 1985;38:394-401.
11. Scordo M, Spina E. Cytochrome P450 polymorphisms and response to antipsychotic therapy. Pharmacogenomics. 2002;3:201-18.
12. de Vries E, Pot H, Conemans J, Uges D. The clinical relevance of routine genotyping of CYP2D6/2C19 null alleles of psychiatric patients. Br J Clin Pharmacol. 2002;53:550P-1P.
13. National Cancer Institute. Risks Associated With Smoking Cigarettes With Low Machine-Measured Yields of Tar and Nicotine. Smoking and Tobacco Control Monograph No. 13. Bethesda, Md: US Department of Health and Human Resources, National Institutes of Health, National Cancer Institute. NIH Pub. No. 02-5074, October 2001.
14. Lerman C, Hughes C, Croyle R, et al. Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing. Prev Med. 2000;31:75-80.
15. Lerman C, Gold K, Audrain J, et al. Incorporating biomarkers of exposure and genetic susceptibility into smoking cessation treatment: Effects on smoking-related cognitions, emotions, and behavior change. Health Psychol. 1997;16:87-99.
16. Audrain J, Boyd N, Roth J, Main D, Caporaso N, Lerman C. Genetic susceptibility testing in smoking-cessation treatment: One-year outcomes of a randomized trial. Addict Behav. 1997;22:741-51.
17. Senior V, Marteau T, Peters T. Will genetic testing for predisposition for disease result in fatalism? A qualitative study of parents' responses to neonatal screening for familial hypercholesterolaemia. Soc Sci Med. 1999;48:1857-60.
18. Leventhal H, Safer M, Panagis D. The impact of communications on the self-regulation of health beliefs, decisions, and behavior. Health Educ Q. 1983;10:3-29.
19. McBride C, Bepler G, Lipkus I, et al. Incorporating genetic susceptibility feedback into a smoking cessation program for African-American smokers with low income. Cancer Epidemiol Biomarkers Prev. 2002;11:521-8.
20. Eddy D. Screening for lung cancer. Ann Intern Med. 1989;111:232-7.
21. Marcus P, Bergstralh E, Fagerstrom R, et al. Lung cancer mortality in the Mayo Lung Project: Impact of extended follow-up. J Natl Cancer Inst. 2000;92:1308-16.
22. Henschke C, McCauley D, Yankelevitz D, et al. Early Lung Cancer Action Project: Overall design and findings from baseline screening. Lancet. 1999;354:99-105.
23. Heffner J, Silvestri G. CT screening for lung cancer: Is smaller better? Am J Respir Crit Care Med. 2002; 165:433-4.
24. Swenson S, Jett J, Sloan J, et al. Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med. 2002;165:508-13.
25. Omenn G, Goodman G, Thornquist M, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med. 1996;334:1150-5.
26. Mattson M, Pollack E, Cullen J. What are the odds that smoking will kill you? Am J Public Health. 1987;77:425-31.
27. Strachan D, Cook D. Health effects of passive smoking. 1. Parental smoking and lower respiratory illness in infancy and early childhood. Thorax. 1997;52:905-14.
28. Strachan D, Cook D. Parental smoking and childhood asthma: Longitudinal and case-control studies. Thorax. 1998;53:204-12.
29. Anderson H, Cook D. Passive smoking and sudden infant death syndrome: Review of the epidemiological evidence. Thorax. 1997;52:1003-9.
30. Boffetta P, Agudo A, Ahrens W, et al. Multicenter case-control study of exposure to environmental tobacco smoke and lung cancer in Europe. J Natl Cancer Inst. 1998;90:1440-50.
31. Steenland K, Thun M, Lally C, Heath C. Environmental tobacco smoke and coronary heart disease in the American Cancer Society CPS-II cohort. Circulation. 1996;94:622-8.
32. Cromwell J, Bartosch W, Fiore M, Hasselblad V, Baker T. Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. JAMA. 1997;278:1759-66.
33. Cross F. Facts and values in risk assessment. Reliability Engineering and System Safety. 1998;59:27-40.
34. Wilson R, Crouch E. Risk assessment and comparisons: An introduction. Science. 1987;236:267-70.
35. Marteau T, Lerman C. Genetic risk and behavioural change. BMJ. 2001;322:1056-9.
36. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin. 2002;52:23-47.